EMA Authorised: Teriflunomide Accord (teriflunomide) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Teriflunomide Accord (teriflunomide) for relapsing-remitting multiple sclerosis. This represents approval of a generic teriflunomide product …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Teriflunomide Accord (teriflunomide)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis, Relapsing-Remitting. MAH: Accord Healthcare S.L.U.. Decision date: 23/02/2026